Eli Lilly CFO Josh Smiley leaves company amid probe on his ‘inappropriate’ behavior

Eli Lilly, the American pharmaceutical company, has been rocked with controversies after its senior vice president and chief financial officer, Josh Smiley, was accused of misconduct. A probe has been launched, and this pushed the CFO to file for resignation.

Smiley stepped down, and with his departure, he also gave up his more than $24 million in cash and equity incentives. The investigation revealed that he went against the company’s rules for employees by showing “inappropriate” behavior.

Eli Lilly announces CFO’s exit

Eli Lilly revealed that Josh Smiley had left the company after the investigation discovered his "inappropriate personal communications" with staff. It was reported that the pharmaceutical firm learned about the allegations of personal relationships between the CFO and an employee.

In response, the company immediately hired a counsel to investigate the case independently. With the swift action of Eli Lilly, Josh Smiley’s offenses were quickly uncovered as well.

"The investigation revealed consensual though inappropriate personal communications with more than one employee and behavior that Lilly leadership concluded exhibited poor judgment by Mr. Smiley," the company’s spokesperson told CNN Business.

Then again, Eli Lilly did not elaborate or give out the details of the case. Thus, it remained unknown to the public about the exact nature of the CFO and the employee’s relationship. But then again, the company reiterated that they don’t condone such behaviors.

"Lilly holds all employees accountable to its core values and strongly believes its executive officers carry an even higher burden in ensuring those values are upheld," the spokesperson further said. "Mr. Smiley did not meet that standard."

New Eli Lilly CFO appointee

Josh Smiley has served the company as its chief financial officer since 2018, and as he leaves, he was replaced by Anat Ashkenazi. She is Eli Lilly’s controller and previously held the senior VP position.

Ashkenazi has been with the company for almost 20 years, so the company is feels assured that she will lead well. "Lilly's core values are integrity, excellence, and respect for people. We expect all employees to live these values, and we expect exemplary conduct from our executives at all times," Forbes quoted David A. Ricks, Eli Lilly’s chairman, and CEO, as saying. "We are confident in Anat's ability to serve as our next CFO has given her impeccable track record of leadership and business success.”